Results 21 to 30 of about 79,803 (167)

Benzodiazepine prescribing patterns among Medicare providers, 2017 to 2023

open access: yesFrontiers in Medicine
IntroductionTo determine whether benzodiazepine (BZD) prescriptions in older adults (>65) generally adhere to the Beers Criteria of the American Geriatrics Society, and whether the likelihood of prescribing an average of > 30 days per beneficiary ...
Olivia Silvernail   +4 more
doaj   +1 more source

Benzodiazepine use in physicians: retrospective 5-year nationwide study in Taiwan

open access: yesBJPsych Open
Background Benzodiazepine use among physicians is an important public health issue related to physicians’ well-being and patient safety. Aims This study aimed to evaluate the patterns and correlates of benzodiazepine use in physicians by comparing ...
Wan-Ju Cheng   +5 more
doaj   +1 more source

Fully Automated Synthesis of Novel TSPO PET Imaging Ligand [18F]Fluoroethyltemazepam

open access: yesMolecules, 2021
Introduction: Benzodiazepines, including temazepam are described as TSPO antagonists. In fact, TSPO was initially described as a peripheral benzodiazepine receptor (PBR) with a secondary binding site for diazepam.
Dario Fiorenza   +5 more
doaj   +1 more source

Influence of SSRI and SNRI co-prescription on benzodiazepine prescription trajectories

open access: yesDrug and Alcohol Dependence Reports
Purpose: This study examined whether co-prescription of selective serotonin reuptake inhibitors (SSRIs) or serotonin or norepinephrine reuptake inhibitors (SNRI)s with benzodiazepines is associated with differences in benzodiazepine prescriptions both ...
Kerry L. Kinney   +4 more
doaj   +1 more source

Designer Benzodiazepines: A Review of Toxicology and Public Health Risks

open access: yesPharmaceuticals, 2021
The rising use of designer benzodiazepines (DBZD) is a cat-and-mouse game between organized crime and law enforcement. Non-prohibited benzodiazepines are introduced onto the global drug market and scheduled as rapidly as possible by international ...
Pietro Brunetti   +4 more
doaj   +1 more source

‘We need more support and doctors that understand the process of tapering …’: A content analysis of free‐text responses to a questionnaire on discontinuing long‐term benzodiazepine receptor agonist use

open access: yesHealth Expectations
Background Many individuals worldwide continue to take benzodiazepine receptor agonists (BZRAs) long term (≥3 months). The aim of this study was to conduct a content analysis of the views and experiences of discontinuing long‐term BZRA use as documented ...
Tom Lynch   +4 more
doaj   +1 more source

New benzodiazepine and Z-hypnotic users and disability pension: an eight-year nationwide observational follow-up study

open access: yesScandinavian Journal of Primary Health Care, 2017
Objective: To compare how newly initiated treatment with benzodiazepines, Z-hypnotics or both associates with the reception of disability pension among 40,661 individuals of a working age. Design: Prescription register study.
Ingunn F. Tvete   +2 more
doaj   +1 more source

Continuous intravenous flumazenil infusion in a patient with chlordiazepoxide toxicity and hepatic encephalopathy

open access: yesJournal of Emergencies, Trauma and Shock, 2015
Flumazenil, a benzodiazepine receptor antagonist, is the drug of choice for the diagnosis and treatment of benzodiazepine overdose. We are presenting a patient with chronic alcoholism and alcoholic liver disease, who came with alcohol withdrawal symptoms
Moh′d Al-Halawani   +5 more
doaj   +1 more source

Benzodiazepine Use Disorder Observed and Diagnosed in a Tertiary Care Pediatric Specialty Clinic: A Descriptive Retrospective Chart Review

open access: yesBJPsych Open
Aims Objectives: In youth and young adults, it is common to encounter non-medical use of benzodiazepines, defined as use without a prescription or use for reasons other than that for which the medication is intended.
Alex Smithers   +3 more
doaj   +1 more source

The Prevalence of Benzodiazepine Usage Among Cardiovascular Patients [PDF]

open access: yesمجله علوم پزشکی صدرا
Introduction: Both benzodiazepines and cardiovascular disease independently increase dementia risk, while anxiety and other psychiatric disorders may exacerbate cardiovascular diseases.
Vahid Mohammadkarimi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy